Literature DB >> 23595519

S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome.

Akiko Shiotani1, Hiroaki Kusunoki, Yoshiki Kimura, Mnabu Ishii, Hiroshi Imamura, Ken-ichi Tarumi, Noriaki Manabe, Tomoari Kamada, Jiro Hata, Ken Haruma.   

Abstract

BACKGROUND: Both ulcerative colitis (UC) and diarrhea-predominant irritable bowel syndrome (IBS-D) are associated with alterations in enteric serotonin (5-HT) signaling. AIMS: The purpose of this study was to compare the rectal and sigmoid colonic mucosal expression of S100A proteins and functional polymorphisms of the 5-HT transporter (5HTT) and interleukin-10 genes in patients with IBS-D or UC with healthy controls.
METHODS: mRNA expression of S100 proteins was measured in sigmoid and rectal biopsies and in rectal epithelium isolated by laser-captured microdissection. Leucocyte DNA was analyzed by PCR-based reaction fragment length polymorphisms and direct sequencing. Clinical symptoms were assessed by the self-rating depression scale and by the gastrointestinal symptom rating scale.
RESULTS: Fifty patients with IBS-D, 56 with UC and 50 healthy controls were studied. Colonic mucosal expression of S100A8 and S100A9 in UC was significantly higher than in IBS or controls and correlated with the UC disease activity index (r = 0.65, p < 0.001). S100A10 expression in the rectal epithelium of the IBS patients was significantly higher (0.643 vs. 0.402, p = 0.01) than in controls and correlated with the SDS scores (r = 0.41, p = 0.002). The frequency of IL10-819 CC genotype was significantly higher in IBS-D (10.7 vs. 0 %, p = 0.047) and UC (16 vs. 0 %, p = 0.007) than that in controls.
CONCLUSION: Overexpression of S100A10 in the rectum may play a role in IBS as it is involved in modulating 5-HT1B receptors. The IL10-819 CC is a candidate genotype for both IBS and UC in Japanese.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23595519     DOI: 10.1007/s10620-013-2677-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  55 in total

1.  Serotonin content and argentaffin and Paneth cell changes in ulcerative colitis.

Authors:  M A VERITY; S M MELLINKOFF; M FRANKLAND; M GREIPEL
Journal:  Gastroenterology       Date:  1962-07       Impact factor: 22.682

2.  Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in Israeli sibling pairs.

Authors:  Y Osher; D Hamer; J Benjamin
Journal:  Mol Psychiatry       Date:  2000-03       Impact factor: 15.992

3.  Enterochromaffin cells in macrophages in ulcerative colitis and irritable colon.

Authors:  A Ahonen; K Kyösola; O Penttilä
Journal:  Ann Clin Res       Date:  1976-02

4.  Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Christopher N Andrews; Adil E Bharucha; Paula J Carlson; Irene Ferber; Debra Stephens; Thomas C Smyrk; Raul Urrutia; Jeroen Aerssens; Leen Thielemans; Hinrich Göhlmann; Ilse van den Wyngaert; Bernard Coulie
Journal:  Gastroenterology       Date:  2006-11-17       Impact factor: 22.682

5.  Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon.

Authors:  K Kyösola; O Penttilä; M Salaspuro
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

Review 6.  The spectrum of behaviors influenced by serotonin.

Authors:  I Lucki
Journal:  Biol Psychiatry       Date:  1998-08-01       Impact factor: 13.382

7.  Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease.

Authors:  S Schreiber; T Heinig; H G Thiele; A Raedler
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

Review 8.  Understanding the signaling and transmission of visceral nociceptive events.

Authors:  Fernando Cervero; Jennifer M A Laird
Journal:  J Neurobiol       Date:  2004-10

Review 9.  Laboratory markers in IBD: useful, magic, or unnecessary toys?

Authors:  S Vermeire; G Van Assche; P Rutgeerts
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

10.  Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

Authors:  Takakazu Oka; Yoko Tamagawa; Sota Hayashida; Yuko Kaneda; Naoki Kodama; Sadatoshi Tsuji
Journal:  Biopsychosoc Med       Date:  2007-11-15
View more
  14 in total

1.  The overlap in the genetic pathogenesis of ulcerative colitis and irritable bowel syndrome.

Authors:  Takeshi Kamiya
Journal:  Dig Dis Sci       Date:  2013-12       Impact factor: 3.199

2.  Association of Serotonin Transporter Promoter Polymorphism (5-HTTLPR) with Microscopic Colitis and Ulcerative Colitis.

Authors:  Arbab Sikander; Saroj Kant Sinha; Kaushal Kishor Prasad; Satya Vati Rana
Journal:  Dig Dis Sci       Date:  2014-12-23       Impact factor: 3.199

Review 3.  A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.

Authors:  Stacy B Menees; Corey Powell; Jacob Kurlander; Akash Goel; William D Chey
Journal:  Am J Gastroenterol       Date:  2015-03-03       Impact factor: 10.864

4.  Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1.

Authors:  A Shiotani; H Kusunoki; M Ishii; H Imamura; N Manabe; T Kamada; J Hata; J L Merchant; K Haruma
Journal:  Neurogastroenterol Motil       Date:  2014-11-27       Impact factor: 3.598

Review 5.  Molecular basis of the irritable bowel syndrome.

Authors:  Anna Vaiopoulou; Georgios Karamanolis; Theodora Psaltopoulou; George Karatzias; Maria Gazouli
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 6.  Irritable bowel syndrome: emerging paradigm in pathophysiology.

Authors:  Yoo Jin Lee; Kyung Sik Park
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

7.  Sigmoid colon mucosal gene expression supports alterations of neuronal signaling in irritable bowel syndrome with constipation.

Authors:  Elizabeth J Videlock; Swapna Mahurkar-Joshi; Jill M Hoffman; Dimitrios Iliopoulos; Charalabos Pothoulakis; Emeran A Mayer; Lin Chang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-22       Impact factor: 4.871

8.  Herb-Partitioned Moxibustion Regulates the TLR2/NF-κB Signaling Pathway in a Rat Model of Ulcerative Colitis.

Authors:  Xiaomei Wang; Yanan Liu; Hongsheng Dong; Luyi Wu; Xiaoming Feng; Zhigang Zhou; Chen Zhao; Huirong Liu; Huangan Wu
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-03       Impact factor: 2.629

Review 9.  The serotonin transporter gene polymorphism (5-HTTLPR) and irritable bowel syndrome: a meta-analysis of 25 studies.

Authors:  Zhi-Feng Zhang; Zhi-Jun Duan; Li-Xia Wang; Dong Yang; Gang Zhao; Lin Zhang
Journal:  BMC Gastroenterol       Date:  2014-02-10       Impact factor: 3.067

10.  Evaluation of global differential gene and protein expression in primary Pterygium: S100A8 and S100A9 as possible drivers of a signaling network.

Authors:  Aihua Hou; Wanwen Lan; Kai Pong Law; Ser Chin Jasmine Khoo; Min Qi Tin; Yoon Pin Lim; Louis Tong
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.